Abstract:Abstract Liver hepatocellular carcinoma (LIHC) is a highly lethal form of cancer that is among the deadliest cancer types globally. In terms of cancer‐related mortality rates, liver cancer ranks among the top three, underscoring the severity of this disease. Insufficient analysis has been conducted to fully understand the potential value of the extracellular matrix (ECM) in immune infiltration and the prognostic stratification of LIHC, despite its recognised importance in the development of this disease. The scRNA‐seq data of GSE149614 was used to conduct single‐cell analysis on 10 LIHC samples. CellChat scores were calculated for seven cell populations in the descending cohort to investigate cellular communication, while PROGENy scores were calculated to determine tumour‐associated pathway scores in different cell populations. The pathway analysis using GO and KEGG revealed the enrichment of ECM‐associated genes in the pathway, highlighting the potential role of the ECM in LIHC development. By utilizing the TCGA‐LIHC cohort, an ECM‐based prognostic model for LIHC was developed using Lasso regression. Immune infiltration scores were calculated using two methods, and the performance of the ECM‐related risk score was evaluated using an independent cohort from the CheckMate study. To determine the precise expression of ECM‐associated risk genes in LIHC, we evaluated hepatocellular carcinoma cell lines using a range of assays, including Western blotting, invasion assays and Transwell assays. Using single‐cell transcriptome analysis, we annotated the spatially‐specific distribution of major immune cell types in single‐cell samples of LIHC. The main cell types identified and annotated included hepatocytes, T cells, myeloid cells, epithelial cells, fibroblasts, endothelial cells and B cells. The utilisation of cellchat and PROGENy analyses enabled the investigation and unveiling of signalling interactions, protein functionalities and the prominent influential pathways facilitated by the primary immune cell types within the LIHC. Numerous tumour pathways, including PI2K, EGFR and TGFb, demonstrated a close correlation with the involvement of ECM in LIHC. Moreover, an evaluation was conducted to assess the primary ECM‐related functional changes and biological pathway enrichment in LIHC. Differential genes associated with ECM were identified and utilised to create prognostic models. The prognostic stratification value of these models for LIHC patients was confirmed through validation in multiple databases. Furthermore, through immune infiltration analysis, it was discovered that ECM might be linked to the irregular expression and regulation of numerous immune cells. Additionally, histone acetylation was mapped against gene mutation frequencies and differential expression profiles. The prognostic stratification efficacy of the ECM prediction model constructed in the context of PD‐1 inhibitor therapy was also examined, and it exhibited strong stratification performance. Cellular experiments, including Western blotting, invasion and Transwell assays, revealed that ECM‐associated risk genes have a promoting effect on the development of LIHC. The creation of biomarkers for LIHC using ECM‐related genes unveiled substantial correlations with immune microenvironmental infiltration and functional mutations in various tumour pathways. This enlightens us to the possibility that the influence of ECM on tumours may extend beyond simply promoting the fibrotic process and the stromal composition of tumours.

Potential regulation and prognostic model of colorectal cancer with extracellular matrix genes

Extracellular Matrix-Based Gene Signature for Predicting Prognosis in Colon Cancer and Immune Microenvironment.

Impact of Extracellular Matrix-Related Genes on the Tumor Microenvironment and Prognostic Indicators in Esophageal Cancer: A Comprehensive Analytical Study

The regulatory roles of T helper cells in distinct extracellular matrix characterization in breast cancer

Extracellular Matrix Biomarkers in Colorectal Cancer

Targeting Extracellular Matrix Interaction in Gastrointestinal Cancer: Immune Modulation, Metabolic Reprogramming, and Therapeutic Strategies

The Integrated Pathway of TGFβ/Snail with TNFα/NFκB May Facilitate the Tumor-Stroma Interaction in the EMT Process and Colorectal Cancer Prognosis.

ECM-Receptor Regulatory Network and Its Prognostic Role in Colorectal Cancer

Integrated bioinformatics analysis of expression and gene regulation network of COL12A1 in colorectal cancer

3D Extracellular Matrix Regulates the Activity of T Cells and Cancer Associated Fibroblasts in Breast Cancer

Extracellular matrix remodeling in the tumor immunity

Transcriptome Profiling of Patient-Derived Tumor Xenografts Suggests Novel Extracellular Matrix-Related Signatures for Gastric Cancer Prognosis Prediction

Extracellular matrix and its therapeutic potential for cancer treatment

A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.

Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods

Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi‐omics approach and prognostic model development

Identification of Endoplasmic Reticulum Stress-Related Subtypes, Infiltration Analysis of Tumor Microenvironment, and Construction of a Prognostic Model in Colorectal Cancer.

A model combing an immune-related genes signature and an extracellular matrix-related genes signature in predicting prognosis of left- and right-sided colon cancer.

Zinc Finger Protein CTCF Regulates Extracellular Matrix (ECM)-Related Gene Expression Associated With the Wnt Signaling Pathway in Gastric Cancer

Epithelial-Mesenchymal Transformation Related Genomic Analysis Reveals Prognostic And Immunogenic Significance In Colorectal Cancer

Extracellular Matrix Characterization in Gastric Cancer Helps to Predict Prognosis and Chemotherapy Response